Medicine & Life Sciences
Type 2 Diabetes Mellitus
100%
Metformin
74%
Glucose
74%
Insulin
66%
Hypoglycemic Agents
47%
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
29%
Insulin Resistance
27%
Glucagon-Like Peptide 1
22%
Hyperglycemia
21%
Obesity
20%
Insulin Secretion
17%
Therapeutics
16%
Peptides
16%
Fatty Acids
15%
Hypoglycemia
15%
Palmitates
14%
2,4-thiazolidinedione
13%
Dipeptidyl-Peptidase IV Inhibitors
12%
Rosiglitazone
12%
Glucagon-Like Peptide-1 Receptor
12%
Incretins
11%
Dipeptidyl Peptidase 4
11%
Weight Loss
11%
Blood Glucose
10%
Thiazolidinediones
10%
Glucagon
10%
Gastric Inhibitory Polypeptide
10%
Pharmaceutical Preparations
10%
Peroxisome Proliferator-Activated Receptors
10%
Placebos
10%
Safety
10%
sibutramine
9%
Sodium-Glucose Transporter 2 Inhibitors
9%
Sodium-Glucose Transport Proteins
9%
BTS 67582
9%
LY3298176
8%
Islets of Langerhans Transplantation
8%
Biguanides
8%
lixisenatide
8%
PPAR gamma
8%
Liver
8%
gastric inhibitory polypeptide receptor
7%
Pioglitazone
7%
glucagon-like peptide 1 (7-36)amide
7%
Leptin
7%
Hormones
7%
Meals
7%
Symporters
7%
Diabetes Complications
7%
Weights and Measures
7%
Chemistry
Insulin Derivative
37%
Insulinotropic
23%
Metformin
20%
Antidiabetic Agent
19%
Glucose
19%
Glucagon-Like Peptide 1
11%
Polypeptide
11%
Metabolic
7%
Saturated Fatty Acid
7%
Leptin
7%
Fatty Acid
7%
Peptide
6%
Glycemic
6%
Hormone
5%
Plasma
5%
Resistance
5%
Ceramide
5%